{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:28:59Z","timestamp":1793834939152,"version":"4.6.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00570"],"award-info":[{"award-number":["PI19\/00570"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The microRNAs (miRNAs) are potential biomarkers for complex pathologies due to their involvement in the regulation of several pathways. Alzheimer Disease (AD) requires new biomarkers in minimally invasive samples that allow an early diagnosis. The aim of this work is to study miRNAS as potential AD biomarkers and their role in the pathology development. In this study, participants (n\u2009=\u200946) were classified into mild cognitive impairment due to AD (MCI-AD, n\u2009=\u200919), preclinical AD (n\u2009=\u20098) and healthy elderly controls (n\u2009=\u200919), according to CSF biomarkers levels (amyloid \u03b242, total tau, phosphorylated tau) and neuropsychological assessment. Then, plasma miRNAomic expression profiles were analysed by Next Generation Sequencing. Finally, the selected miRNAs were validated by quantitative PCR (q-PCR). A panel of 11 miRNAs was selected from omics expression analysis, and 8 of them were validated by q-PCR. Individually, they did not show statistically significant differences among participant groups. However, a multivariate model including these 8 miRNAs revealed a potential association with AD for three of them. Specifically, relatively lower expression levels of miR-92a-3p and miR-486-5p are observed in AD patients, and relatively higher levels of miR-29a-3p are observed in AD patients. These biomarkers could be involved in the regulation of pathways such as synaptic transmission, structural functions, cell signalling and metabolism or transcription regulation. Some plasma miRNAs (miRNA-92a-3p, miRNA-486-5p, miRNA-29a-3p) are slightly dysregulated in AD, being potential biomarkers of the pathology. However, more studies with a large sample size should be carried out to verify these results, as well as to further investigate the mechanisms of action of these miRNAs.<\/jats:p>","DOI":"10.1038\/s41598-022-19862-6","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T14:06:28Z","timestamp":1663337188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Plasma microRNAs as potential biomarkers in early Alzheimer disease expression"],"prefix":"10.1038","volume":"12","author":[{"given":"Carmen","family":"Pe\u00f1a-Bautista","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Tarazona-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitana","family":"Braza-Boils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Balaguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ferr\u00e9-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio J.","family":"Ca\u00f1ada-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Baquero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Ch\u00e1fer-Peric\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"19862_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2015.05.001","volume":"87","author":"SM Hammond","year":"2015","unstructured":"Hammond, S. M. An overview of microRNAs. Adv. Drug Deliv. Rev. 87, 3\u201314. https:\/\/doi.org\/10.1016\/j.addr.2015.05.001 (2015).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"19862_CR2","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","volume":"141","author":"TX Lu","year":"2018","unstructured":"Lu, T. X. & Rothenberg, M. E. MicroRNA. J. Allergy Clin. Immunol. 141, 1202\u20131207. https:\/\/doi.org\/10.1016\/j.jaci.2017.08.034 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"19862_CR3","unstructured":"W.H. Organization, Dementia, (2021). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia"},{"key":"19862_CR4","doi-asserted-by":"publisher","first-page":"674","DOI":"10.2174\/157015911798376181","volume":"9","author":"DM Niedowicz","year":"2011","unstructured":"Niedowicz, D. M., Nelson, P. T. & Paul Murphy, M. Alzheimers Disease: Pathological Mechanisms and Recent Insights. Curr. Neuropharmacol. 9, 674\u2013684. https:\/\/doi.org\/10.2174\/157015911798376181 (2011).","journal-title":"Curr. Neuropharmacol."},{"key":"19862_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.freeradbiomed.2015.02.028","volume":"83","author":"A Lloret","year":"2015","unstructured":"Lloret, A., Fuchsberger, T., Giraldo, E. & Vi\u00f1a, J. Molecular mechanisms linking amyloid \u03b2 toxicity and Tau hyperphosphorylation in Alzheimer\u05f3s disease. Free Radic. Biol. Med. 83, 186\u2013191. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.02.028 (2015).","journal-title":"Free Radic. Biol. Med."},{"key":"19862_CR6","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.5213\/inj.1938184.092","volume":"23","author":"S-H Yang","year":"2019","unstructured":"Yang, S.-H. Cellular and molecular mediators of neuroinflammation in Alzheimer disease. Int. Neurourol. J. 23, S54-62. https:\/\/doi.org\/10.5213\/inj.1938184.092 (2019).","journal-title":"Int. Neurourol. J."},{"key":"19862_CR7","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/j.1532-5415.2000.tb02603.x","volume":"48","author":"C Berr","year":"2000","unstructured":"Berr, C., Balansard, B., Arnaud, J., Roussel, A.-M. & Alp\u00e9rovitch, A. Cognitive decline is associated with systemic oxidative stress: The EVA Study. J. Am. Geriatr. Soc. 48, 1285\u20131291. https:\/\/doi.org\/10.1111\/j.1532-5415.2000.tb02603.x (2000).","journal-title":"J. Am. Geriatr. Soc."},{"key":"19862_CR8","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.jalz.2018.06.2857","volume":"14","author":"GL Bowman","year":"2018","unstructured":"Bowman, G. L. et al. Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults. Alzheimer\u2019s Dement. 14, 1640\u20131650. https:\/\/doi.org\/10.1016\/j.jalz.2018.06.2857 (2018).","journal-title":"Alzheimer\u2019s Dement."},{"key":"19862_CR9","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.14506.1","author":"J Weller","year":"2018","unstructured":"Weller, J. & Budson, A. Current understanding of Alzheimer\u2019s disease diagnosis and treatment. F1000Res https:\/\/doi.org\/10.12688\/f1000research.14506.1 (2018).","journal-title":"F1000Res"},{"key":"19862_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 7, 263\u2013269. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005 (2011).","journal-title":"Alzheimer\u2019s Dement."},{"key":"19862_CR11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert, M. S. et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the national institute on aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 7, 270\u2013279. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.008 (2011).","journal-title":"Alzheimer\u2019s Dement."},{"key":"19862_CR12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling, R. A. et al. Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the national institute on aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 7, 280\u2013292. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.003 (2011).","journal-title":"Alzheimer\u2019s Dement."},{"key":"19862_CR13","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","volume":"14","author":"H Hampel","year":"2018","unstructured":"Hampel, H. et al. Blood-based biomarkers for Alzheimer disease: Mapping the road to the clinic. Nat. Rev. Neurol. 14, 639\u2013652. https:\/\/doi.org\/10.1038\/s41582-018-0079-7 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"19862_CR14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.2174\/138920209788185252","volume":"10","author":"O Maes","year":"2009","unstructured":"Maes, O., Chertkow, H., Wang, E. & Schipper, H. MicroRNA: Implications for Alzheimer disease and other human CNS disorders. Curr. Genomics 10, 154\u2013168. https:\/\/doi.org\/10.2174\/138920209788185252 (2009).","journal-title":"Curr. Genomics"},{"key":"19862_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00665","author":"F Angelucci","year":"2019","unstructured":"Angelucci, F. et al. MicroRNAs in Alzheimer\u2019s disease: Diagnostic markers or therapeutic agents?. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2019.00665 (2019).","journal-title":"Front Pharmacol."},{"key":"19862_CR16","doi-asserted-by":"publisher","first-page":"6156","DOI":"10.1007\/s12035-019-1500-y","volume":"56","author":"S Swarbrick","year":"2019","unstructured":"Swarbrick, S., Wragg, N., Ghosh, S. & Stolzing, A. Systematic review of miRNA as biomarkers in Alzheimer\u2019s disease. Mol. Neurobiol. 56, 6156\u20136167. https:\/\/doi.org\/10.1007\/s12035-019-1500-y (2019).","journal-title":"Mol. Neurobiol."},{"key":"19862_CR17","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3233\/JAD-210307","volume":"83","author":"H He","year":"2021","unstructured":"He, H. et al. Novel plasma miRNAs as biomarkers and therapeutic targets of Alzheimer\u2019s disease at the prodromal stage. J. Alzheimer\u2019s Dis. 83, 779\u2013790. https:\/\/doi.org\/10.3233\/JAD-210307 (2021).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"19862_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2021.113864","volume":"199","author":"S Song","year":"2022","unstructured":"Song, S., Lee, J. U., Jeon, M. J., Kim, S. & Sim, S. J. Detection of multiplex exosomal miRNAs for clinically accurate diagnosis of Alzheimer\u2019s disease using label-free plasmonic biosensor based on DNA-Assembled advanced plasmonic architecture. Biosens. Bioelectron. 199, 113864. https:\/\/doi.org\/10.1016\/j.bios.2021.113864 (2022).","journal-title":"Biosens. Bioelectron."},{"key":"19862_CR19","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/mp.2014.127","volume":"20","author":"L Cheng","year":"2015","unstructured":"Cheng, L. et al. Prognostic serum miRNA biomarkers associated with Alzheimer\u2019s disease shows concordance with neuropsychological and neuroimaging assessment. Mol. Psychiatry 20, 1188\u20131196. https:\/\/doi.org\/10.1038\/mp.2014.127 (2015).","journal-title":"Mol. Psychiatry"},{"key":"19862_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031630","volume":"7","author":"F Cordero","year":"2012","unstructured":"Cordero, F., Beccuti, M., Arigoni, M., Donatelli, S. & Calogero, R. A. Optimizing a massive parallel sequencing workflow for quantitative miRNA expression analysis. PLoS ONE 7, e31630. https:\/\/doi.org\/10.1371\/journal.pone.0031630 (2012).","journal-title":"PLoS ONE"},{"key":"19862_CR21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s12859-018-2296-x","volume":"19","author":"N Kulkarni","year":"2018","unstructured":"Kulkarni, N. et al. Reproducible bioinformatics project: A community for reproducible bioinformatics analysis pipelines. BMC Bioinform. 19, 349. https:\/\/doi.org\/10.1186\/s12859-018-2296-x (2018).","journal-title":"BMC Bioinform."},{"key":"19862_CR22","unstructured":"R.C. Team., R: A language and environment for statistical computing, (2018). https:\/\/www.r-project.org\/"},{"key":"19862_CR23","unstructured":"S. Andrews, FastQC: A quality control tool for high throughtput sequence data 2010, (n.d.). www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/"},{"key":"19862_CR24","doi-asserted-by":"publisher","DOI":"10.14806\/ej.17.1.200","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. https:\/\/doi.org\/10.14806\/ej.17.1.200 (2011).","journal-title":"EMBnet J."},{"key":"19862_CR25","doi-asserted-by":"publisher","first-page":"D152","DOI":"10.1093\/nar\/gkq1027","volume":"39","author":"A Kozomara","year":"2011","unstructured":"Kozomara, A. & Griffiths-Jones, S. miRBase: Integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 39, D152\u2013D157. https:\/\/doi.org\/10.1093\/nar\/gkq1027 (2011).","journal-title":"Nucleic Acids Res."},{"key":"19862_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1000386","volume":"5","author":"SM Rumble","year":"2009","unstructured":"Rumble, S. M. et al. SHRiMP: Accurate mapping of short color-space reads. PLoS Comput. Biol. 5, e1000386. https:\/\/doi.org\/10.1371\/journal.pcbi.1000386 (2009).","journal-title":"PLoS Comput. Biol."},{"key":"19862_CR27","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1093\/bioinformatics\/btr046","volume":"27","author":"M David","year":"2011","unstructured":"David, M., Dzamba, M., Lister, D., Ilie, L. & Brudno, M. SHRiMP2: Sensitive yet practical short read mapping. Bioinformatics 27, 1011\u20131012. https:\/\/doi.org\/10.1093\/bioinformatics\/btr046 (2011).","journal-title":"Bioinformatics"},{"key":"19862_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003118","volume":"9","author":"M Lawrence","year":"2013","unstructured":"Lawrence, M. et al. Software for computing and annotating genomic ranges. PLoS Comput. Biol. 9, e1003118. https:\/\/doi.org\/10.1371\/journal.pcbi.1003118 (2013).","journal-title":"PLoS Comput. Biol."},{"key":"19862_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00227","author":"J Song","year":"2017","unstructured":"Song, J. & Kim, Y.-K. Identification of the role of miR-142\u20135p in Alzheimer\u2019s disease by comparative bioinformatics and cellular analysis. Front Mol. Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2017.00227 (2017).","journal-title":"Front Mol. Neurosci."},{"key":"19862_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-016-0053-5","author":"SS Sorensen","year":"2016","unstructured":"Sorensen, S. S., Nygaard, A.-B. & Christensen, T. miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer\u2019s disease and other types of dementia\u2013an exploratory study. Transl. Neurodegener. https:\/\/doi.org\/10.1186\/s40035-016-0053-5 (2016).","journal-title":"Transl. Neurodegener."},{"key":"19862_CR31","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1186\/s12885-019-6037-y","volume":"19","author":"L Wu","year":"2019","unstructured":"Wu, L. et al. Genome-wide study of salivary microRNAs as potential noninvasive biomarkers for detection of nasopharyngeal carcinoma. BMC Cancer 19, 843. https:\/\/doi.org\/10.1186\/s12885-019-6037-y (2019).","journal-title":"BMC Cancer"},{"key":"19862_CR32","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20211420","author":"B Zhu","year":"2021","unstructured":"Zhu, B., Gu, S., Wu, X., He, W. & Zhou, H. Bioinformatics analysis of tumor-educated platelet microRNAs in patients with hepatocellular carcinoma. Biosci. Rep. https:\/\/doi.org\/10.1042\/BSR20211420 (2021)."},{"key":"19862_CR33","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1373\/clinchem.2019.303271","volume":"65","author":"V Kloten","year":"2019","unstructured":"Kloten, V. et al. Multicenter evaluation of circulating plasma MicroRNA extraction technologies for the development of clinically feasible reverse transcription quantitative PCR and next-generation sequencing analytical work flows. Clin. Chem. 65, 1132\u20131140. https:\/\/doi.org\/10.1373\/clinchem.2019.303271 (2019).","journal-title":"Clin. Chem."},{"key":"19862_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.679206","author":"H Liu","year":"2021","unstructured":"Liu, H. et al. Increased expression of plasma miRNA-320a and let-7b-5p in heroin-dependent patients and its clinical significance. Front Psychiatry https:\/\/doi.org\/10.3389\/fpsyt.2021.679206 (2021).","journal-title":"Front Psychiatry"},{"key":"19862_CR35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13195-019-0501-4","volume":"11","author":"D Siedlecki-Wullich","year":"2019","unstructured":"Siedlecki-Wullich, D. et al. Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer\u2019s disease. Alzheimers Res. Ther. 11, 46. https:\/\/doi.org\/10.1186\/s13195-019-0501-4 (2019).","journal-title":"Alzheimers Res. Ther."},{"key":"19862_CR36","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ymthe.2016.10.010","volume":"25","author":"X Li","year":"2017","unstructured":"Li, X. et al. Correcting miR92a-vGAT-mediated GAB aergic Dysfunctions rescues human tau-induced anxiety in mice. Mol. Ther. 25, 140\u2013152. https:\/\/doi.org\/10.1016\/j.ymthe.2016.10.010 (2017).","journal-title":"Mol. Ther."},{"key":"19862_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165937","author":"S Kumar","year":"2020","unstructured":"Kumar, S. & Reddy, P. H. The role of synaptic microRNAs in Alzheimer\u2019s disease. Biochim. Biophys. Acta (BBA) Mol. Basis Dis. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165937 (2020).","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Basis Dis."},{"key":"19862_CR38","doi-asserted-by":"publisher","first-page":"32050","DOI":"10.1074\/jbc.M113.504365","volume":"288","author":"L Zhu","year":"2013","unstructured":"Zhu, L. et al. Reduction of synaptojanin 1 accelerates A\u03b2 clearance and attenuates cognitive deterioration in an Alzheimer mouse model. J. Biol. Chem. 288, 32050\u201332063. https:\/\/doi.org\/10.1074\/jbc.M113.504365 (2013).","journal-title":"J. Biol. Chem."},{"key":"19862_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s40478-020-00954-1","volume":"8","author":"K Ando","year":"2020","unstructured":"Ando, K. et al. The lipid phosphatase synaptojanin 1 undergoes a significant alteration in expression and solubility and is associated with brain lesions in Alzheimer\u2019s disease. Acta Neuropathol. Commun. 8, 79. https:\/\/doi.org\/10.1186\/s40478-020-00954-1 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"19862_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226368","volume":"14","author":"M Maesako","year":"2019","unstructured":"Maesako, M., Zoltowska, K. M. & Berezovska, O. Synapsin 1 promotes A\u03b2 generation via BACE1 modulation. PLoS ONE 14, e0226368. https:\/\/doi.org\/10.1371\/journal.pone.0226368 (2019).","journal-title":"PLoS ONE"},{"key":"19862_CR41","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.neurobiolaging.2014.11.006","volume":"36","author":"PJ Chac\u00f3n","year":"2015","unstructured":"Chac\u00f3n, P. J. et al. Cerebellin 4, a synaptic protein, enhances inhibitory activity and resistance of neurons to amyloid-\u03b2 toxicity. Neurobiol. Aging. 36, 1057\u20131071. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.11.006 (2015).","journal-title":"Neurobiol. Aging."},{"key":"19862_CR42","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1523\/JNEUROSCI.4736-04.2005","volume":"25","author":"M Yao","year":"2005","unstructured":"Yao, M. Amyloid-induced neuronal apoptosis involves c-Jun N-terminal kinase-dependent downregulation of Bcl-w. J. Neurosci. 25, 1149\u20131158. https:\/\/doi.org\/10.1523\/JNEUROSCI.4736-04.2005 (2005).","journal-title":"J. Neurosci."},{"key":"19862_CR43","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000091436","volume":"21","author":"J Brettschneider","year":"2006","unstructured":"Brettschneider, J. et al. The neurofilament heavy chain (NfHSMI35) in the cerebrospinal fluid diagnosis of Alzheimer\u2019s disease. Dement. Geriatr. Cogn. Disord. 21, 291\u2013295. https:\/\/doi.org\/10.1159\/000091436 (2006).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"19862_CR44","doi-asserted-by":"publisher","first-page":"e1148","DOI":"10.1038\/tp.2017.113","volume":"7","author":"NJ Ashton","year":"2017","unstructured":"Ashton, N. J. et al. Plasma REST: A novel candidate biomarker of Alzheimer\u2019s disease is modified by psychological intervention in an at-risk population. Transl. Psychiatry 7, e1148\u2013e1148. https:\/\/doi.org\/10.1038\/tp.2017.113 (2017).","journal-title":"Transl. Psychiatry"},{"key":"19862_CR45","doi-asserted-by":"publisher","first-page":"16122","DOI":"10.18632\/oncotarget.15109","volume":"8","author":"S Nagaraj","year":"2017","unstructured":"Nagaraj, S. et al. Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer\u2019s disease patients from non-demented subjects. Oncotarget 8, 16122\u201316143. https:\/\/doi.org\/10.18632\/oncotarget.15109 (2017).","journal-title":"Oncotarget"},{"key":"19862_CR46","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1365-2990.2010.01076.x","volume":"36","author":"M Shioya","year":"2010","unstructured":"Shioya, M. et al. Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. Neuropathol. Appl. Neurobiol. 36, 320\u2013330. https:\/\/doi.org\/10.1111\/j.1365-2990.2010.01076.x (2010).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"19862_CR47","first-page":"1565","volume":"8","author":"X Lei","year":"2015","unstructured":"Lei, X., Lei, L., Zhang, Z., Zhang, Z. & Cheng, Y. Downregulated miR-29c correlates with increased BACE1 expression in sporadic Alzheimer\u2019s disease. Int. J. Clin. Exp. Pathol. 8, 1565\u20131574 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"19862_CR48","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.3892\/mmr.2015.3728","volume":"12","author":"G Yang","year":"2015","unstructured":"Yang, G. et al. MicroRNA-29c targets \u03b2-site amyloid precursor protein-cleaving enzyme 1 and has a neuroprotective role in vitro and in vivo. Mol. Med. Rep. 12, 3081\u20133088. https:\/\/doi.org\/10.3892\/mmr.2015.3728 (2015).","journal-title":"Mol. Med. Rep."},{"key":"19862_CR49","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1007\/s12035-015-9156-8","volume":"53","author":"M M\u00fcller","year":"2016","unstructured":"M\u00fcller, M. et al. MicroRNA-29a Is a candidate biomarker for Alzheimer\u2019s disease in cell-free cerebrospinal fluid. Mol. Neurobiol. 53, 2894\u20132899. https:\/\/doi.org\/10.1007\/s12035-015-9156-8 (2016).","journal-title":"Mol. Neurobiol."},{"key":"19862_CR50","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1093\/emboj\/21.7.1524","volume":"21","author":"T Hashimoto","year":"2002","unstructured":"Hashimoto, T. CLAC: A novel Alzheimer amyloid plaque component derived from a transmembrane precursor, CLAC-P\/collagen type XXV. EMBO J. 21, 1524\u20131534. https:\/\/doi.org\/10.1093\/emboj\/21.7.1524 (2002).","journal-title":"EMBO J."},{"key":"19862_CR51","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1006\/exnr.1996.0043","volume":"138","author":"A Afagh","year":"1996","unstructured":"Afagh, A., Cummings, B. J., Cribbs, D. H., Cotman, C. W. & Tenner, A. J. Localization and cell association of C1q in Alzheimer\u2019s disease Brain. Exp. Neurol. 138, 22\u201332. https:\/\/doi.org\/10.1006\/exnr.1996.0043 (1996).","journal-title":"Exp. Neurol."},{"key":"19862_CR52","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1074\/jbc.M403628200","volume":"280","author":"L S\u00f6derberg","year":"2005","unstructured":"S\u00f6derberg, L. et al. Characterization of the Alzheimer\u2019s disease-associated CLAC protein and identification of an amyloid \u03b2-peptide-binding site. J. Biol. Chem. 280, 1007\u20131015. https:\/\/doi.org\/10.1074\/jbc.M403628200 (2005).","journal-title":"J. Biol. Chem."},{"key":"19862_CR53","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.cell.2010.11.053","volume":"144","author":"G Bai","year":"2011","unstructured":"Bai, G. et al. Presenilin-dependent receptor processing is required for axon guidance. Cell 144, 106\u2013118. https:\/\/doi.org\/10.1016\/j.cell.2010.11.053 (2011).","journal-title":"Cell"},{"key":"19862_CR54","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0185-17.2017","author":"B Wang","year":"2017","unstructured":"Wang, B. et al. The amyloid precursor protein is a conserved receptor for slit to mediate axon guidance. ENeuro https:\/\/doi.org\/10.1523\/ENEURO.0185-17.2017 (2017).","journal-title":"ENeuro"},{"key":"19862_CR55","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1101\/gad.338046.120","volume":"34","author":"X Ding","year":"2020","unstructured":"Ding, X. et al. The daam2\u2013VHL\u2013Nedd4 axis governs developmental and regenerative oligodendrocyte differentiation. Genes Dev. 34, 1177\u20131189. https:\/\/doi.org\/10.1101\/gad.338046.120 (2020).","journal-title":"Genes Dev."},{"key":"19862_CR56","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jalz.2017.09.008","volume":"14","author":"KJ Sellers","year":"2018","unstructured":"Sellers, K. J. et al. Amyloid \u03b2 synaptotoxicity is Wnt-PCP dependent and blocked by fasudil. Alzheimer\u2019s Dement. 14, 306\u2013317. https:\/\/doi.org\/10.1016\/j.jalz.2017.09.008 (2018).","journal-title":"Alzheimer\u2019s Dement."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19862-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19862-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19862-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T02:02:58Z","timestamp":1663380178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19862-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["19862"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-19862-6","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]},"assertion":[{"value":"23 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15589"}}